Thank you to Erin Harris for hosting our CEO, Mike Severino, on Cell & Gene: The Podcast. It was an insightful conversation discussing Tessera Therapeutics' mission, groundbreaking science, and our exciting preclinical progress across our programs. Catch the full episode here: https://bit.ly/4d4M0NQ
Tessera Therapeutics
Biotechnology Research
Somerville, MA 33,498 followers
We are pioneering Gene Writing (TM) beyond its current limitations.
About us
Our Gene Writing™ technology advances genetic medicine beyond its current limitations. Learn more at http://TesseraTherapeutics.com
- Website
-
http://tesseratx.com
External link for Tessera Therapeutics
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Somerville, MA
- Type
- Privately Held
Locations
-
Primary
Somerville, MA 02143, US
Employees at Tessera Therapeutics
Updates
-
This week, our COO Hari Pujar, will be speaking at this year's RNA Leaders USA Conference. Learn more here: https://lnkd.in/dhTfJ4VB
-
In case you missed it, our CSO, Mike Holmes, recently spoke to @DrugTargetRev about the RNA #GeneWriters data we presented at #ASGCT2024. Read the article to learn more about the progress of our #GeneWriting platform in alpha-1 antitrypsin deficiency (AATD): https://lnkd.in/exCSwezU
Tessera Therapeutics: addressing Alpha-1 Antitrypsin Deficiency
https://www.drugtargetreview.com
-
Last week, #TeamTessera gathered in our backyard at #TheBlockatBoyntonYards for Friends & Family Day! At Tessera, we value our employees' hard work and tenacity. To help them recharge, we offer flexible work arrangements so they can spend quality time with loved ones. We understand the importance of connection, and opportunities like this allow us to bridge our professional and personal lives in meaningful ways. #Community #SummerMemories #FriendsandFamily #Flexibility
-
Tune in to hear CGTLive's latest episode where our CEO, Mike Severino, discussed Tessera's Gene Writing and delivery platforms and our advancements towards in vivo gene editing at #ASGCT2024. Learn more about the progress we are making across multiple programs and how these cutting-edge technologies are paving the future of genetic medicine: https://lnkd.in/eCFUdHsq
Michael Severino on In Vivo Gene Editing With RNA Gene Writers
cgtlive.com
-
Our annual summer outing at Fenway Park was a hit! ⚾ Enjoying quality time with colleagues, along with their friends and families reinforces the positive and supportive environment we've cultivated here at Tessera. We believe these moments of team bonding contribute to enhanced trust, productivity, and a foundation for continued success. #TeamTessera #SummerOuting #Redsox #CompanyCulture #Community
-
Exciting news from Flagship Pioneering as they announce the raise of $3.6 billion to fuel breakthrough innovations that transform human health and sustainability. We are proud to be #FlagshipFounded and part of an ecosystem of companies – present and future – taking bold scientific leaps to deliver a better future for all. Hear more from Flagship Founder and CEO Noubar Afeyan: https://lnkd.in/egcEgNrR
Flagship Pioneering Raises $3.6B for 'New Wave' of Health, AI Innovation
bloomberg.com
-
In case you missed it, we announced non-human primate data showing therapeutically relevant levels of in vivo rewriting of the gene responsible for alpha-1 antitrypsin deficiency at the Federation of American Societies for Experimental Biology (FASEB) 2024 Genome Engineering conference. Read more about the data here: https://lnkd.in/edAJUStY
-
This June, our #TesserOUT ERG championed inclusion with a month of action. From marching in the Boston Pride Parade to hosting vibrant company-wide celebrations and partnering with LGBTQIA+-owned businesses, they fostered a welcoming community for all. At Tessera, we understand the journey for equality continues, and remain committed to building a more inclusive future, year-round. Learn more about life at Tessera: https://bit.ly/4bbx3ZA #Pride2024 #TeamTessera #Inclusion #Diversity
-
This year at the 2024 #MontySummit, our CEO, Michael Severino, spoke about the potential impact of #GeneticMedicine on patients living with serious diseases. At Tessera, we're building the #FutureofGeneticMedicine, a field we believe will become a new pillar in medicine.
In reflecting on their journey as a physician scientist, Michael Severino, CEO of Tessera Therapeutics shared firsthand accounts of the profound impact of genetic medicine at the 2024 #MontySummit. Originally trained as an HIV immunologist, Severino grappled with the limitations of traditional treatments when faced with devastating diseases. As we navigate the frontier of genetic medicine, key questions emerge: How can scientific innovation be translated into practical solutions for patients? What strategies can address rare genetic diseases, advanced cancers, and more common ailments like Alzheimer's? The ability to transform despair into hope lays the foundation for success, not just in medical breakthroughs but also in building remarkable companies dedicated to genetic medicine. Genetic medicine has the potential to revolutionizes healthcare, offering hope to millions and curing once-incurable diseases. Discover more about the impact of genetic medicine on common diseases and breakthroughs in genetic therapy in the full 2024 Summit session on the future of medicine featuring Geoffrey von Maltzahn (Flagship Pioneering), Nicole K. Paulk, PhD (Siren Biotechnology) and Michael Severino. https://lnkd.in/gNQtFFrS #GeneticMedicine #HealthcareInnovation #MedicalBreakthroughs #FutureOfMedicine #Innovation #Technology